Fluocinonide
RxNorm 103456· FLUOCINONIDE· TOPICAL
Corticosteroid [EPC] · Preferred Pharmaceuticals Inc.
Indications and usage
INDICATIONS AND USAGE Fluocinonide Cream, USP 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and administration
DOSAGE AND ADMINISTRATION Fluocinonide cream 0.05% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Contraindications
CONTRAINDICATIONS Fluocinonide cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- drug ineffective762
- psoriasis550
- rash449
- pruritus419
- diarrhoea287
- fatigue287
- nausea280
- pain277
- off label use270
- headache260
- product use in unapproved indication215
- arthralgia211
- product dose omission issue184
- dermatitis atopic181
- dyspnoea175
- erythema174
Adverse reactions (label)
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, miliaria. To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
View more: Full FDA label on DailyMed →Label effective 20260417